Although the sale and use of marijuana as a recreational substance is a federal offense in the U.S., as of June 25, 2019, it is approved in 11 states and the District of Columbia for recreational use and in 33 states for medicinal purposes — particularly for treating pain associated with cancer and for nausea and loss of appetite associated with chemotherapy treatment.
Patients with mesothelioma cope with symptoms of the disease and side effects of cancer treatment such as chest pain and chemotherapy-induced nausea. A number of clinical trials found evidence that medical marijuana may help some patients manage cancer-related symptoms and side effects of cancer treatment.
As with all forms of herbal medicine, patients should consult with their oncologist before using this type of complementary treatment because it may interfere with conventional treatments.
Benefits and Side Effects of Medical Marijuana
In clinical trials, medical marijuana was found effective for:
Improved sleep quality
Despite its benefits, medical marijuana may also have side effects, including:
Low blood pressure
Slowed food digestion
Patients report that side effects are generally mild, but vary depending on the strain of marijuana and how much is consumed. Researchers have not reported benefits or side effects of marijuana as a treatment for mesothelioma.
Speak With a Mesothelioma Doctor About Medical Marijuana
We can connect you with the nation's top mesothelioma specialists and cancer centers.Get Free Help Now
Scientific Research on Medical Marijuana in Cancer Care
Most of the scientific research on medical marijuana in cancer care has happened outside of the U.S. because marijuana remains illegal at the federal level. Growing support for legalization of medical marijuana may promote cancer research in the future, but current research is limited in the U.S.
Global research efforts have increased in recent years because of a growing interest in the potential role of medical marijuana in cancer care. The research extends beyond the well-known tetrahydrocannabinol chemical, known as THC, to include other compounds, such as CBD, collectively known as cannabinoids.
The research has looked at marijuana not only as a means to control cancer symptoms and treatment side effects, but also as an anti-cancer therapy. Studies in test tubes and in mice indicate that several types of cancer may respond to cannabis as an anti-cancer therapy. Some cancer cells die when exposed to cannabinoids, and some stop spreading.
It appears that certain cancer cells actually have cannabinoid receptors, but the precise function remains largely unknown. There isn’t enough research on how marijuana affects mesothelioma tumor progression.
Medical Marijuana Research for Cancer Symptoms & Treatment Side Effects
In 2019, Expert Opinion on Investigational Drugs published a review of the medical literature on the use of medical marijuana in cancer care. It found evidence that it may help cancer patients cope with chemotherapy-induced nausea and vomiting, cancer-related pain, anorexia and cachexia syndrome, insomnia and anxiety.
In 2018, Current Pain Headache Reports published a review of randomized, controlled clinical trials involving medical cannabis for neuropathic pain, which is a common side effect of chemotherapy. Over the last 20 years, about a dozen clinical trials reported significant relief of neuropathic pain using marijuana over a placebo. The results and tolerability of marijuana for neuropathy was found comparable to prescription drugs.
In 2015, Cochrane Database of Systematic Reviews published a review of 23 randomized, controlled clinical trials involving cancer patients receiving medical marijuana for nausea and vomiting caused by chemotherapy. The study reported that patients receiving marijuana experienced less nausea and vomiting than patients receiving a placebo.
It also reported that marijuana controlled nausea and vomiting just as well as conventional anti-nausea drugs, and the patients who received both preferred marijuana over anti-nausea drugs. However, patients receiving marijuana were more likely to drop out of the trials because of side effects (such as dizziness or sedation) than patients receiving placebos or anti-nausea drugs.
Research on Medical Marijuana as an Anti-Cancer Therapy
A 2016 study published in Progress In Neuro-Psychopharmacology & Biological Psychiatry found THC and other cannabinoids can kill cancer cells and limit their spreading. The study also noted research in animals that showed cannabis enhanced the effect of cancer drugs designed to stop tumor growth and spreading.
A 2016 study published in Current Oncology found THC and CBD limited the growth of neuroblastoma in test tube studies and mice studies. Of the two cannabinoids, CBD was more active against this cancer.
A 2014 study published in Oncotarget reported certain cannabinoid compounds in medical marijuana can kill a variety of cancer cells and block them from spreading. Researchers cited studies showing cannabinoids having anti-cancer effects in the following cancers: Lung, breast, prostate, skin, pancreatic, brain, bone, oral, thyroid and lymphoma.
Cannabinoids May Promote Tumor Growth
It is important to note some laboratory research indicates cannabinoids may promote tumor growth in certain cancers. For example, a 2004 test tube study published in Cancer Research found THC promoted the growth of lung cancer and glioblastoma, a type of brain cancer.
A 2005 test tube study published in The Journal of Immunology found THC enhanced the growth and spreading of breast cancer. In 2000, the same journal published a study on mice with lung cancer and found THC accelerated tumor growth by limiting parts of the immune system that control cancer.
Further research in humans is required to fully understand how the chemicals in marijuana affect different types of cancer.
Edible Medical Marijuana
Patients with mesothelioma or lung cancer have weakened lungs and experience trouble breathing. For these patients, consuming edible marijuana may be preferable to smoking it to avoid aggravation of lung tissues.
There are some differences between smoked and edible marijuana:
When marijuana is inhaled, the effects are felt almost immediately. When eaten, it takes longer to take effect because of the digestive process. The effect can take from 20 minutes to two or more hours to be fully felt, but the average time is around 90 minutes.
Many patients find the psychoactive effects of edible marijuana are milder and the body relief is stronger. This is sometimes more effective for cancer patients who seek relief from physical symptoms. The effects may also last longer.
Edible medical marijuana comes in a variety of types:
The most popular and most recognizable forms of edible marijuana are baked goods. Items such as brownies and cookies are made with cannabis-infused butter. Hash oil or hash-infused butter tends to have a higher concentration of marijuana, so less cannabis can be used, making the flavor milder. This type of marijuana can also be made into chocolates.
Other edibles include hard candies, cold drinks and teas. It is important to follow dosing instructions carefully and not overeat marijuana edibles. Patients are recommended to start with a very small dose to gauge the effects.
For patients who are watching calories, fat or sugar, there are alternatives to heavy baked goods:
Tinctures are placed under the tongue for a short amount of time and then swallowed. According to some patients, the effect of tinctures is less sedating than edibles made with cannabis butter, and it is absorbed more quickly.
Cannabis capsules usually contain a mix of cannabis and other oils, or other oils infused with cannabis. Patients take these like they would any other pill.
For patients who don’t prefer edibles, topical marijuana products are becoming more widely available:
Topical products are primarily used to reduce body pain and inflammation in the area they are applied. This may help mesothelioma patients experiencing cancer-related pain such as chest pain or bone pain caused by growing tumors.
Some states that haven’t enacted medical marijuana laws allow the sale of non-psychoactive cannabinoid products such as CBD topical creams.
Connect With Other Mesothelioma Survivors & Caregivers
Join other mesothelioma patients online and learn valuable information in our free support group.Register Now
Since marijuana is not readily available to many patients, drug companies have developed synthetic versions of THC, the psychoactive ingredient in marijuana.
A synthetic form of THC called Marinol (dronabinol) was approved by the U.S. Food and Drug Administration (FDA) as an appetite stimulant and for nausea.
Cesamet (nabilone) is another drug that contains a synthetic cannabinoid similar to THC that was approved to treat nausea and vomiting caused by chemotherapy.
Patients who have tried synthetic and natural versions of marijuana often say marijuana in its natural form is more effective for symptom relief than the synthetic variety. Marinol and Cesamet can also have serious side effects that aren’t a risk with natural THC, including seizures, irregular heartbeat, vision changes, headaches and severe or persistent dizziness.
Regulation and Legalization of Medical Marijuana
Regulations on marijuana began in the early 1900s.
Various pieces of legislation affected the regulation and criminalization of marijuana such as:
Harrison Narcotics Act
Marihuana Tax Act of 1937
Narcotics Control Act
Controlled Substances Act
In 1970, the Controlled Substances Act classified marijuana as a Schedule I substance having “no accepted medical use.”
The country’s attitude toward medical marijuana began to shift in the late 1970s. In 1978, the National Institute on Drug Abuse (NIDA) supplied seven patients with marijuana after their physicians applied for the Expanded Access (compassionate use) program.
In 1991, 53% of oncologists agreed that marijuana should be available by prescription and 66% said it helped cancer patients treat the side effects of chemotherapy.
The New England Journal of Medicine published an editorial calling for the rescheduling of marijuana in 1997, and in 2008 the American College of Physicians stated that it supported non-smoked THC. The organization also called for exemption from criminal prosecution for patients.
After California legalized the drug in 1996, other states followed. Presently, 33 states, the District of Columbia, Guam, Puerto Rico and the U.S. Virgin Islands have legalized medical marijuana.
Recreational marijuana became legal to purchase in Colorado and Washington in 2014. Since then, a total of 11 states and one territory have approved recreational marijuana.
States That Have Legalized Recreational Marijuana
District of Columbia
States That Have Legalized Medical Marijuana
|Alaska||1 oz usable; 6 plants (3 mature, 3 immature)|
|Arizona||2.5 oz usable; 12 plants|
|Arkansas||2.5 oz usable per 14-day period|
|California||8 oz usable; 6 mature or 12 immature plants|
|Colorado||2 oz usable; 6 plants (3 mature, 3 immature)|
|Connecticut||2.5 oz usable|
|District of Columbia||2 oz useable; 6 plants (3 mature, 3 immature)|
|Delaware||6 oz usable|
|Florida||35-day supply (amount not specified)|
|Hawaii||4 oz usable; 10 plants|
|Illinois||2.5 oz of usable cannabis during a 14-day period|
|Maine||2.5 oz usable; 6 plants|
|Maryland||30-day supply; no more than 120 grams (approximately 4 oz)|
|Massachusetts||60-day supply (10 oz)|
|Michigan||2.5 oz usable; 12 plants|
|Minnesota||30-day supply of non-smokable marijuana|
|Montana||1 oz usable; 4 plants (mature); 12 seedlings|
|Nevada||2.5 oz usable; 12 plants|
|New Hampshire||2 oz of usable cannabis during a 10-day period|
|New Jersey||2 oz usable|
|New Mexico||6 oz usable; 16 plants (4 mature, 12 immature)|
|New York||30-day supply of non-smokable marijuana|
|North Dakota||3 oz per 14-day period|
|Ohio||Maximum of a 90-day supply; amount to be determined|
|Oregon (only state to accept out-of-state applications)||24 oz usable; 24 plants (6 mature, 18 immature)|
|Rhode Island||2.5 oz usable; 12 plants|
|Utah||113 grams of unprocessed cannabis|
|Vermont||2 oz usable; 9 plants (2 mature, 7 immature)|
|Washington||8 oz usable; 6 plants|
|West Virginia||30-day supply|
Talk with Your Oncologist
If you live in a state that offers medical marijuana, ask your oncologist how it might benefit or interfere with your treatment plan. People assume it couldn’t hurt to take a natural substance, but cannabis products contain antioxidants that may protect cancer cells from the wanted effects of chemotherapy and radiation therapy.
This means certain types of medical marijuana might have the potential to block your anti-cancer treatments from working properly. Your oncologist is your best resource for guidance on this matter.
A number of mesothelioma survivors have said they spoke with their doctor before using medical marijuana as a complementary therapy to conventional treatment, which is known as integrative oncology.
Medical Marijuana Experiences for Mesothelioma Survivors
One mesothelioma survivor, Andy Ashcraft, said he used cannabis oil for years and believed it helped him cope with mesothelioma. His wife and caregiver thoroughly researched how to dose and administer cannabis oil to cancer patients before Andy began taking it.
Another survivor, Pete K., said he used edible medical marijuana to lessen the side effects of chemotherapy.
California resident and mesothelioma survivor Jim Huff said he uses cannabis oils to control his cancer and promote sleep.
While research shows medical marijuana may help cancer patients cope with pain, nausea, anxiety, lack of appetite and insomnia, it is best to discuss how you want to use marijuana with your doctor to get their approval first and make sure you take the right product, at the right time, without interfering with your treatment plan.
19 Cited Article Sources
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
ProCon. (2019, September 20). Should Marijuana be a Medical Option?
Retrieved from: https://medicalmarijuana.procon.org/
ProCon. (2019, July 24). Legal Medical Marijuana States and DC.
Retrieved from: https://medicalmarijuana.procon.org/view.resource.php?resourceID=000881
National Cancer Institute. (2019, July 16). Cannabis and cannabinoids.
Retrieved from: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq/
Grinspoon, P. (2019, June 25). Medical marijuana.
Retrieved from: https://www.health.harvard.edu/blog/medical-marijuana-2018011513085
Turgeman, I. & Bar-Sela, G. (2019). Cannabis for cancer - illusion or the tip of an iceberg: A review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology.
Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/30572744
Lee, G. et al. (2018). Medical Cannabis for Neuropathic Pain.
Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/29388063
American Cancer Society. (2017, March 4). Marijuana and Cancer.
Retrieved from: https://www.cancer.org/treatment/treatments-and-side-effects/complementary-and-alternative-medicine/marijuana-and-cancer.html
Bridgeman, M.B. & Abazia, D.T. (2017). Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.
Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/
Valesco, G. et al. (2016). The use of cannabinoids as anticancer agents.
Retrieved from: https://www.sciencedirect.com/science/article/pii/S0278584615001190
Smith, L.A. et al. (2015). Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/26561338/
Chakravarti, B., Ravi, J, & Ganju, R.K. (2014, August). Cannabinoids as therapeutic agents in cancer: Current status and future implications.
Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/25115386
McKenna, G.J. (2014). The Current Status of Medical Marijuana in the United States.
Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998227/
Wing, N. (2013, August 30). These states are most likely to legalize pot next.
Retrieved from: http://www.huffingtonpost.com/2013/08/30/marijuana-legalization-states_n_3838866.html
U.S. Department of Justice. (2013, August 29). Justice department announces update to marijuana enforcement policy.
Retrieved from: http://www.justice.gov/opa/pr/2013/August/13-opa-974.html
Berkeley Patients Care Collective. (2011, January 20). A beginner's guide for medical cannabis.
Retrieved from: https://berkeleypatientscare.com/a-beginners-guide-for-medical-cannabis/
McKallip, R.J., Nagarkatti, M., & Nagarkatti, P.S. (2005). Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.
Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/15749859
Hart, S., Fischer, O.M., & Ullrich, A. (2004). Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor.
Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/15026328
Mack, A. & Joy, J. Marijuana as Medicine? Washington, DC: National Academies Press, 2000.
- Zhu, L.X. et al. (2000). Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. Retrieved from: http://www.jimmunol.org/content/165/1/373.short
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Share this article
Last Modified December 18, 2019